Antibody Therapeutics Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Rising Technological Advancements in the Development of Antibody Therapeutics
   3. Market Restraints
      1. High Development Costs and Complex Regulatory Pathways
      2. Limited Standardization and Reproducibility
   4. Market Opportunity
      1. Personalized Medicines
   5. Market Trends
      1. Growth in Liquid Biopsy Adoption
      2. Integration of Artificial Intelligence (AI) and Machine Learning
5. MARKET SEGMENTATION
   1. By Format
      1. Monoclonal Antibody
      2. Polyclonal Antibody Therapy
      3. Antibody Fragment
      4. Bispecific Antibody
      5. Other Antibody Formats
   2. By Disease Area
      1. Autoimmune & Inflammatory Diseases
      2. Oncology
      3. Hematology
      4. Osteology
      5. Immunology
      6. Neurology
      7. Infectious Diseases
      8. Other Diseases Areas
   3. By Route of Administration
      1. Intravenous
      2. Subcutaneous
      3. Other Route of Administration
   4. By Source
      1. Human
      2. Humanized
      3. Chimeric
      4. Other Sources
   5. By End User
      1. Hospitals
      2. Long-term Care Facilities
      3. Other End Users
   6. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Abbvie Inc.
      2. AstraZeneca
      3. Amgen Inc.
      4. Bristol-Myers Squibb
      5. Biogen Inc.
      6. F. Hoffman-La Roche Ltd.
      7. Johnson & Johnson
      8. Merck KGaA
      9. Novartis AG
      10. Regeneron Pharmaceuticals Inc.
      11. Sanofi
7. MARKET OPPORTUNITIES AND FUTURE TREND

Frequently Asked Questions

Q.1. What is the projected market value of the global antibody therapeuticsmarket?

The global market of antibody therapeuticsis projected to reach USD908.27Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global antibody therapeutics market?

The global antibody therapeuticsmarket has an estimated annual growth rate of 14.0%.

Q.3. What are the recent trends of antibody therapeuticsmarket?

Rise of bispecific and multispecific antibodies and expansion of antibody-drug conjugates (ADCs)are some of the major trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in antibody therapeutics?

The major companies profiled in this report include Abbvie Inc., AstraZeneca, Amgen Inc., Bristol-Myers Squibb, Biogen Inc., F. Hoffman-La Roche Ltd., Johnson & Johnson, Merck KGaA, Novartis AG, Regeneron Pharmaceuticals Inc., Sanofi, among others.  

Q.5. Which is the largest regional market in the antibody therapeutics?

North America is the largest regional market for antibody therapeutics.